Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin

Authors

Megan E. McNamara, Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, District of Columbia.
Leonardo Tjahjono, Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.

Document Type

Journal Article

Publication Date

8-1-2025

Journal

JAAD case reports

Volume

62

DOI

10.1016/j.jdcr.2025.01.047

Keywords

autoimmune; connective tissue disease; dermatomyositis; deucravacitinib; interface dermatitis; tyrosine kinase 2

APA Citation

McNamara, Megan E. and Tjahjono, Leonardo, "Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin" (2025). GW Authored Works. Paper 7850.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/7850

Department

Dermatology